Experimental HIV Vaccine Proves Ineffective, Researchers Say After Halting South African Clinical Trial

Devex: Promising HIV vaccine proves ineffective
“A vaccine trial against HIV in South Africa has proven ineffective, prompting the National Institute of Allergy and Infectious Diseases to stop it. Scientists were cautiously optimistic about the trial, which involved 5,407 HIV-negative volunteers at 14 sites across South Africa. The announcement made on Monday underscores the difficulty involved in creating a vaccine for sub-Saharan Africa, which has the highest HIV epidemic in the world, according to Dr. Larry Corey, principal investigator at the HIV Vaccine Trials Network, headquartered at the Fred Hutchinson Cancer Research Center, which conducted the trial…” (Jerving, 2/4).

Additional coverage of the trial is available from AP, CNN, and Science.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.